comparemela.com
Home
Live Updates
Chiesi acquires pioneering therapeutic monoclonal antibodies
Chiesi acquires pioneering therapeutic monoclonal antibodies
Chiesi acquires pioneering therapeutic monoclonal antibodies portfolio against EMAP II as potential treatment for PAH
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Related Keywords
Italy ,
Ohio ,
United States ,
Cleveland ,
Prnewswire Chiesi Farmaceutici ,
Thomas Eichholtz ,
Matthias Clauss ,
Irina Petrache ,
Indiana University ,
Chiesi Group ,
National Jewish Health ,
A Chiesi Group ,
Allinaire Therapeutic ,
Health ,
Pr Newswire ,